πŸ”₯πŸ” BizChicken πŸ”πŸ”₯

Companies Similar to Ardelyx, Inc.

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

Aytu BioPharma, Inc.

Aytu BioPharma, Inc. logo
Market Cap: Lowest
Employees: Low

Adzenys XR-ODT

Aytu Biopharma, Inc. is a specialty pharmaceutical company focused on developing and commercializing novel therapeutics and consumer healthcare products in the United States and internationally. They offer products for the treatment of ADHD, allergies, fluoride deficiency, cough, and insomnia.

Tags: ADHD, Allergies, Fluoride Deficiency, Healthcare, Insomnia, Pharmaceuticals, Therapeutics

Symbol: AYTU

Recent Price: $1.61

Industry: Drug Manufacturers - Specialty & Generic

CEO: Mr. Joshua R. Disbrow

Sector: Healthcare

Employees: 102

Address: 373 Inverness Parkway, Englewood, CO 80112

Phone: 720 437 6580

Last updated: 2024-12-31

Allarity Therapeutics, Inc.

Allarity Therapeutics, Inc. logo
Market Cap: Lowest
Employees: Lowest

Stenoparib, Dovitinib, IXEMPRA, Li Pla Cis, 2X-111

Allarity Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing oncology therapeutics using companion diagnostics and drug response predictor technology.

Tags: biopharmaceutical, clinical trials, companion diagnostics, oncology, therapeutics

Symbol: ALLR

Recent Price: $1.12

Industry: Biotechnology

CEO: Mr. Thomas H. Jensen

Sector: Healthcare

Employees: 5

Address: 210 Broadway, Cambridge, MA 02139

Phone: 401 426 4664

Last updated: 2024-12-31

Amgen Inc.

Amgen Inc. logo
Market Cap: Highest
Employees: Highest

Enbrel, Neulasta, Prolia, Xgeva, Otezla, Aranesp, KYPROLIS, Repatha, Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide, focusing on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience.

Tags: biotechnology, bone health, cardiovascular, healthcare, inflammation, neuroscience, oncology, pharmaceuticals, therapeutics

Symbol: AMGN

Recent Price: $259.30

Industry: Drug Manufacturers - General

CEO: Mr. Robert A. Bradway

Sector: Healthcare

Employees: 26700

Address: One Amgen Center Drive, Thousand Oaks, CA 91320-1799

Phone: 805 447 1000

Leadership

  • Robert A. Bradway, Chairman and Chief Executive Officer
  • James Bradner, Executive Vice President, Research and Development, and Chief Scientific Officer
  • Sean Bruich, Senior Vice President Artificial Intelligence and Data
  • Paul Burton, Senior Vice President and Chief Medical Officer
  • Raymond Deshaies, Senior Vice President, Global Research
  • Jackie Elbonne, Senior Vice President, Quality and Chief Quality Officer
  • Murdo Gordon, Executive Vice President, Global Commercial Operations
  • Jonathan Graham, Executive Vice President and General Counsel and Secretary
  • Peter Griffith, Executive Vice President and Chief Financial Officer
  • Nancy Grygiel, Senior Vice President, Worldwide Compliance & Business Ethics and Chief Compliance Officer
  • Narimon Honarpour, Senior Vice President, Global Development
  • Vikram Karnani, Executive Vice President, and President, Global Commercial Operations and Medical Affairs (Rare Disease)
  • My Linh Kha, Senior Vice President and General Manager, Japan Asia-Pacific
  • Rachna Khosla, Senior Vice President, Business Development
  • Gilles Marrache, Senior Vice President, Regional General Manager
  • Derek Miller, Senior Vice President, Human Resources
  • Jerry Murry, Senior Vice President, Process Development
  • Kave Niksefat, Senior Vice President, Global Marketing and Access
  • Arleen Paulino, Senior Vice President, Manufacturing
  • Annalisa Pizzarello, Senior Vice President, Results Delivery Office
  • Greg Portner, Senior Vice President, Global Government Affairs and Policy
  • Anton Rabushka, Senior Vice President, Finance
  • Emily Razaqi, Senior Vice President, Obesity and Related Conditions
  • David M. Reese, Executive Vice President and Chief Technology Officer
  • Esteban Santos, Executive Vice President, Operations
  • Darryl Sleep, Senior Vice President, Global Medical
  • Jean-Charles Soria, Senior Vice President, Research and Development
  • Susan Sweeney, Executive Vice President, Obesity and Related Conditions
  • Mark J. Taisey, Senior Vice President, Global Regulatory Affairs and Strategy
  • Susie Tappouni, Head of Corporate Affairs
  • Ian Thompson, Senior Vice President, U.S. Business Operations
  • Brenda Torres, Senior Vice President, Global Supply Chain
  • Alper Üreten, Vice President, Commercialization and Program Management
  • Wanda M. Austin, Retired President and Chief Executive Officer, The Aerospace Corporation
  • Michael V. Drake, President, University of California
  • Brian J. Druker, Physician-Scientist and Professor of Medicine, Oregon Health & Science University (OHSU), Director of the OHSU Knight Cancer Institute and JELD-WEN Chair of Leukemia Research, and Associate Dean for Oncology, OHSU School of Medicine
  • Robert A. Eckert, Lead Independent Director, Chairman Emeritus, Mattel, Inc.
  • Greg C. Garland, Former Executive Chairman and Former Chairman and Chief Executive Officer, Phillips 66
  • Charles M. Holley, Jr., Former Executive Vice President and Chief Financial Officer of Wal-Mart Stores, Inc.
  • S. Omar Ishrak, Former Executive Chairman and Chairman of the Board of Directors, Medtronic plc
  • Tyler Jacks, David H. Koch Professor of Biology, Massachusetts Institute of Technology and Founding Director of the David H. Koch Institute for Integrative Cancer Research
  • Mary E. Klotman, Executive Vice President for Health Affairs of Duke University, Dean of the Duke University School of Medicine, and Chief Academic Officer of Duke Health
  • Ellen J. Kullman, Executive Chair of the Board and Former President and Chief Executive Officer of Carbon, Inc.
  • Amy E. Miles, Former Chair of the Board and Chief Executive Officer, Regal Entertainment Group, Inc.

Last updated: 2024-12-31

Omeros Corporation

Omeros Corporation logo
Market Cap: Low
Employees: Low

Narsoplimab

Omeros Corporation is a commercial-stage biopharmaceutical company that focuses on discovering, developing, and commercializing therapeutics for inflammation, immune-related cancers, and addictive disorders.

Tags: Narsoplimab, addiction, biopharmaceutical, clinical trials, drug development, immune system, therapeutics

Symbol: OMER

Recent Price: $9.74

Industry: Biotechnology

CEO: Dr. Gregory A. Demopulos M.D.

Sector: Healthcare

Employees: 198

Address: The Omeros Building, Seattle, WA 98119

Phone: 206 676 5000

Last updated: 2024-12-31

Syndax Pharmaceuticals, Inc.

Syndax Pharmaceuticals, Inc. logo
Market Cap: High
Employees: Low

SNDX-5613, SNDX-6352 (axatilimab), Entinostat

Syndax Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for cancer treatment, including innovative candidates like SNDX-5613 and SNDX-6352. It collaborates with notable institutions like the National Cancer Institute and has a license agreement with Kyowa Hakko Kirin Co., Ltd.

Tags: Collaborations, Entinostat, Monoclonal Antibody, SNDX-5613, SNDX-6352, biopharmaceutical, cancer therapy, clinical-stage

Symbol: SNDX

Recent Price: $12.52

Industry: Biotechnology

CEO: Mr. Michael A. Metzger M.B.A.

Sector: Healthcare

Employees: 184

Address: 35 Gatehouse Drive, Waltham, MA 02451

Phone: 781 419 1400

Last updated: 2024-12-31

Tenax Therapeutics, Inc.

Tenax Therapeutics, Inc. logo
Market Cap: Lowest
Employees: Lowest

TNX-103, TNX-102 (levosimendan), TNX-201 (imatinib)

Tenax Therapeutics, Inc. is a specialty pharmaceutical company that focuses on identifying, developing, and commercializing products for cardiovascular and pulmonary diseases. The company is involved in developing medications such as TNX-103 and TNX-102 (levosimendan) for pulmonary hypertension and heart failure, and TNX-201 (imatinib) for pulmonary arterial hypertension.

Tags: TNX-102, TNX-103, TNX-201, cardiovascular, pharmaceutical, pulmonary diseases

Symbol: TENX

Recent Price: $6.55

Industry: Biotechnology

CEO: Mr. Christopher T. Giordano

Sector: Healthcare

Employees: 5

Address: ONE Copley Parkway, Morrisville, NC 27560

Phone: 919 855 2100

Last updated: 2024-12-31

Adial Pharmaceuticals, Inc.

Adial Pharmaceuticals, Inc. logo
Market Cap: Lowest
Employees: Lowest

AD04

Adial Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing therapeutics for addiction and related disorders. Its lead product, AD04, is in Phase III clinical trial for alcohol use disorder treatment.

Tags: AD04, addiction treatment, alcohol use disorder, biopharmaceutical, clinical trials

Symbol: ADIL

Recent Price: $1.03

Industry: Biotechnology

CEO: Mr. Cary John Claiborne MBA

Sector: Healthcare

Employees: 4

Address: 1180 Seminole Trail, Charlottesville, VA 22901

Phone: 434 422 9800

Last updated: 2024-12-31

Akebia Therapeutics, Inc.

Akebia Therapeutics, Inc. logo
Market Cap: Low
Employees: Low

Vadadustat

Akebia Therapeutics, Inc. is a biopharmaceutical company focused on developing and commercializing therapeutics for kidney disease patients, with a lead product vadadustat for treating anemia due to chronic kidney disease.

Tags: CKD, anemia, biopharmaceutical, chronic kidney disease, kidney diseases, therapeutics, vadadustat

Symbol: AKBA

Recent Price: $1.85

Industry: Biotechnology

CEO: Mr. John P. Butler MBA

Sector: Healthcare

Employees: 167

Address: 245 First Street, Cambridge, MA 02142

Phone: 617 871 2098

Last updated: 2024-12-31

Amylyx Pharmaceuticals, Inc.

Amylyx Pharmaceuticals, Inc. logo
Market Cap: Low
Employees: Medium

AMX0035

Amylyx Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. Their leading product, AMX0035, is aimed at ALS treatment.

Tags: ALS, AMX0035, biopharmaceutical, neurodegenerative diseases, therapeutics

Symbol: AMLX

Recent Price: $3.84

Industry: Biotechnology

CEO: Mr. Joshua B. Cohen

Sector: Healthcare

Employees: 384

Address: 43 Thorndike Street, Cambridge, MA 02141

Phone: 617 682 0917

Leadership

  • Linda A. Arsenault, Chief Human Resources Officer
  • Camille L. Bedrosian, MD, Chief Medical Officer
  • Josh Cohen, Co-CEO & Co-Founder
  • James M. Frates, Chief Financial Officer
  • Tom Holmes, Chief Technical Operations Officer
  • Justin Klee, Co-CEO & Co-Founder
  • Gina M. Mazzariello, Chief Legal Officer & General Counsel
  • Rudolph Tanzi, PhD, Founding Chair of the Amylyx SAB
  • Wally Gilbert, Special Advisor
  • Kari Firestone, Director
  • Paul Fonteyne, Director
  • George Milne, Chairman
  • Daphne Quimi, Director
  • Bernhardt G. Zeiher, MD, FACP, FCCP, Director

Last updated: 2024-12-31

Ardelyx, Inc.

Ardelyx, Inc. logo
Market Cap: High
Employees: Low

tenapanor

Ardelyx, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing medicines for gastrointestinal and cardiorenal therapeutic areas, including treatments for irritable bowel syndrome with constipation and hyperphosphatemia.

Tags: CKD, biopharmaceutical, cardiorenal, gastrointestinal, hyperkalemia, hyperphosphatemia, metabolic acidosis, tenapanor

Symbol: ARDX

Recent Price: $5.25

Industry: Biotechnology

CEO: Mr. Michael G. Raab

Sector: Healthcare

Employees: 267

Address: 400 Fifth Avenue, Waltham, MA 02451

Phone: 510 745 1700

Leadership

  • Justin Renz, Chief Financial & Operations Officer
  • Eric Foster, Chief Commercial Officer
  • Elizabeth Grammer, Esq., Chief Legal & Administrative Officer
  • Laura Williams, MD MPH, Chief Medical Officer
  • Robert Blanks, MS RAC, Chief Regulatory Affairs & Quality Assurance Officer
  • David Rosenbaum, PhD, Chief Development Officer
  • Mike Kelliher, Executive Vice President, Corporate Development and Strategy
  • Charon Spencer, Chief Human Resources Officer
  • David Mott, Chairman
  • Robert Bazemore, Director
  • William A. Bertrand, Jr., JD, Director
  • Muna Bhanji, R.Ph, Director
  • Onaiza Cadoret-Manier, Director
  • Mike Raab, Director
  • Richard Rodgers, Director

Last updated: 2024-12-31

Axsome Therapeutics, Inc.

Axsome Therapeutics, Inc. logo
Market Cap: High
Employees: Medium

AXS-05, AXS-07, AXS-12, AXS-14

Axsome Therapeutics, Inc. is a biopharmaceutical company focused on developing novel therapies for central nervous system disorders such as major depressive disorder, migraine, narcolepsy, and fibromyalgia.

Tags: CNS disorders, biopharmaceutical, clinical trials, depression, fibromyalgia, migraine, narcolepsy

Symbol: AXSM

Recent Price: $84.78

Industry: Biotechnology

CEO: Dr. Herriot Tabuteau M.D.

Sector: Healthcare

Employees: 589

Address: 22 Cortlandt Street, New York, NY 10007

Phone: 212 332 3241

Leadership

  • Herriot Tabuteau, MD, CHIEF EXECUTIVE OFFICER
  • Nick Pizzie, CPA, MBA, CHIEF FINANCIAL OFFICER
  • Mark Jacobson, MA, CHIEF OPERATING OFFICER
  • Hunter Murdock, Esq., GENERAL COUNSEL
  • ari Maizel, Executive Vice President, Head of Commercial
  • Mark Coleman, MD, DIRECTOR
  • Roger Jeffs, PhD, DIRECTOR
  • Susan Mahony, PhD, MBA, DIRECTOR
  • Mark Saad, DIRECTOR

Last updated: 2024-12-31

BioCryst Pharmaceuticals, Inc.

BioCryst Pharmaceuticals, Inc. logo
Market Cap: High
Employees: Medium

ORLADEYO

Bio Cryst Pharmaceuticals, Inc. is a biotechnology company focused on discovering novel, oral, and small-molecule medicines, with marketed products including RAPIVAB and ORLADEYO, and a pipeline featuring BCX9930, BCX9250, and Galidesivir.

Tags: biotechnology, clinical trials, hereditary angioedema, influenza treatment, oral medicines, small-molecule medicines

Symbol: BCRX

Recent Price: $7.53

Industry: Biotechnology

CEO: Mr. Jon P. Stonehouse

Sector: Healthcare

Employees: 536

Address: 4505 Emperor Boulevard, Durham, NC 27703

Phone: 919 859 1302

Last updated: 2024-12-31

iTeos Therapeutics, Inc.

iTeos Therapeutics, Inc. logo
Market Cap: Medium
Employees: Low

inupadenant, EOS-448

Iteos Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of immuno-oncology therapeutics. Their product pipeline includes inupadenant and EOS-448, which are in various phases of clinical trials.

Tags: biopharmaceutical, clinical trials, immuno-oncology, therapeutics

Symbol: ITOS

Recent Price: $7.29

Industry: Biotechnology

CEO: Dr. Michel Detheux Ph.D.

Sector: Healthcare

Employees: 157

Address: 321 Arsenal Street, Cambridge, MA 02472-5710

Phone: 339 217 0161

Leadership

  • Michel DETHEUX, President, Chief Executive Officer
  • Matt CALL, Chief Operating Officer
  • Matthew GALL, Chief Financial Officer
  • Yvonne MCGRATH, Chief Scientific Officer
  • David Feltquate, Chief Medical Officer
  • Philippe BRANTEGEM, Executive Vice President of Human Resources
  • Adi OSOVSKY, Executive Vice President of Legal
  • David HALLAL, Chair of the Board
  • Aaron DAVIS,
  • Jill DESIMONE,
  • David LEE,
  • Tim VAN HAUWERMEIREN,
  • Tony HO,
  • Robert IANNONE,
  • Ann RHOADS,

Last updated: 2024-12-31

Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Incorporated logo
Market Cap: High
Employees: Lowest

Kyprolis, Evomela, Veklury, Teriparatide, Vaxneuvance, Pneumosil, Rylaze, Nexterone, Zulresso, Noxafil-IV

Ligand Pharmaceuticals Incorporated is a biopharmaceutical company focused on developing or acquiring technologies to aid pharmaceutical companies in discovering and developing medicines. The company's commercial programs include treatments for multiple myeloma, COVID-19, osteoporosis, invasive diseases, childhood pneumonia, and acute lymphoblastic leukemia.

Tags: biopharmaceutical, commercial programs, disease treatment, medicine development, pharmaceutical technology

Symbol: LGND

Recent Price: $105.76

Industry: Biotechnology

CEO: Mr. Todd C. Davis Ph.D.

Sector: Healthcare

Employees: 58

Address: 5980 Horton Street, EmeryVille, CA 94608

Phone: 858 550 7500

Last updated: 2024-12-31

Nurix Therapeutics, Inc.

Nurix Therapeutics, Inc. logo
Market Cap: High
Employees: Low

NX-2127, NX-5948, NX-1607, NX-0255

Nurix Therapeutics, Inc. is a biopharmaceutical company that focuses on developing small molecule therapies for cancer and immune disorders, with products targeting BTK and CBL-B proteins. The company collaborates with Gilead Sciences and Sanofi.

Tags: BTK degrader, CBL-B inhibitor, biopharmaceutical, cancer, clinical trials, immune disorders

Symbol: NRIX

Recent Price: $18.64

Industry: Biotechnology

CEO: Dr. Arthur T. Sands M.D., Ph.D.

Sector: Healthcare

Employees: 284

Address: 1700 Owens Street, San Francisco, CA 94158

Phone: 415 660 5320

Last updated: 2024-12-31

Acelyrin, Inc.

Acelyrin, Inc. logo
Market Cap: Medium
Employees: Low

izokibep

Acelyrin, Inc. is a clinical biopharma company focused on developing and commercializing transformative medicines, with key products targeting conditions like Hidradenitis Suppurativa and Psoriatic Arthritis.

Tags: Biopharma, Clinical Trials, Hidradenitis Suppurativa, Psoriatic Arthritis, Transformative Medicines

Symbol: SLRN

Recent Price: $3.08

Industry: Biotechnology

CEO: Ms. Mina Kim

Sector: Healthcare

Employees: 93

Address: 4149 Liberty Canyon Road, Agoura Hills, CA 91301

Phone: 805-730-0360

Last updated: 2024-12-31

Trevena, Inc.

Trevena, Inc. logo
Market Cap: Lowest
Employees: Lowest

OLINVYK (Oliceridine) injection

Trevena, Inc. is a biopharmaceutical company focused on developing and commercializing novel medicines for central nervous system disorders, with products like OLINVYK and collaborations such as with Imperial College London.

Tags: COVID-19, acute pain, biopharmaceutical, central nervous system disorders, chronic pain, migraine

Symbol: TRVN

Recent Price: $1.50

Industry: Biotechnology

CEO: Ms. Carrie L. Bourdow

Sector: Healthcare

Employees: 23

Address: 955 Chesterbrook Boulevard, Chesterbrook, PA 19087

Phone: 610 354 8840

Leadership

  • Carrie L. Bourdow, President and Chief Executive Officer
  • Mark A. Demitrack, MD, Senior Vice President, Chief Medical Officer
  • Barry Shin, Executive Vice President, Chief Operating Officer and Chief Financial Officer
  • Robert T. Yoder, Senior Vice President, Chief Business Officer, Head of Commercial Operations & Chief Compliance Officer
  • Scott Braunstein, M.D., Lead Independent Director
  • Dr. Mark Corrigan, Acting CEO
  • Marvin H. Johnson, Jr., Board Member
  • Jake R. Nunn, Board Member
  • Anne M. Phillips, M.D., Board Member
  • Barbara Yanni, Board Member

Last updated: 2024-12-31

Y-mAbs Therapeutics, Inc.

Y-mAbs Therapeutics, Inc. logo
Market Cap: Medium
Employees: Low

DANYELZA

Y-m Abs Therapeutics, Inc., is a commercial-stage biopharmaceutical company focused on developing and commercializing novel antibody-based therapeutic products for cancer treatment in the United States.

Tags: DANYELZA, antibody, biopharmaceutical, cancer treatment, clinical trials

Symbol: YMAB

Recent Price: $7.76

Industry: Biotechnology

CEO: Mr. Michael Rossi

Sector: Healthcare

Employees: 100

Address: 230 Park Avenue, New York, NY 10169

Phone: 646 885 8505

Leadership

  • Michael Rossi, President and Chief Executive Officer
  • Thomas Gad, Founder, Vice Chairman of the Board of Directors, Chief Business Officer
  • Torben Lund-Hansen, SVP, Chief Technical Officer
  • Peter Pfreundschuh, Chief Financial Officer
  • Vignesh Rajah, SVP, Chief Medical Officer
  • Joris Wilms, SVP, Chief Operating Officer
  • Sue Smith, SVP, Chief Commercial Officer
  • Norman LaFrance, Chief Development Officer
  • Johan Wedell-Wedellsborg, Chairman
  • Ashutosh Tyagi, M.D.,
  • James I. Healy, Chairman
  • David N. Gill,
  • Laura J. Hamill,
  • Mary Tagliaferri, M.D.,

Last updated: 2024-12-31

Eagle Pharmaceuticals, Inc.

Eagle Pharmaceuticals, Inc. logo
Market Cap: Lowest
Employees: Low

Ryanodex, Belrapzo, Bendeka, EP-4104, PEMFEXY, EA-114, Vasopressin

Eagle Pharmaceuticals, Inc. specializes in the development and commercialization of pharmaceutical products targeting diseases of the central nervous system, metabolic critical care, and oncology in the U.S. Notable products include Ryanodex for malignant hyperthermia, and oncology treatments Belrapzo and Bendeka.

Tags: antitoxin, central nervous system, collaboration agreements, critical care, disease treatment, oncology, pharmaceutical

Symbol: EGRX

Recent Price: $0.50

Industry: Drug Manufacturers - Specialty & Generic

CEO: Mr. Michael Graves

Sector: Healthcare

Employees: 134

Address: 50 Tice Boulevard, Woodcliff Lake, NJ 07677

Phone: 201 326 5300

Last updated: 2024-12-31

Terns Pharmaceuticals, Inc.

Terns Pharmaceuticals, Inc. logo
Market Cap: Medium
Employees: Low

TERN-101, TERN-201, TERN-501, TERN-601

Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing small-molecule therapies for non-alcoholic steatohepatitis (NASH) and obesity, incorporating products like TERN-101, TERN-201, TERN-501, and TERN-601.

Tags: NASH, biopharmaceutical, clinical trials, obesity, pharmaceutical research

Symbol: TERN

Recent Price: $7.15

Industry: Biotechnology

CEO: Ms. Amy L. Burroughs M.B.A.

Sector: Healthcare

Employees: 66

Address: 1065 East Hillsdale Boulevard, Foster City, CA 94404

Phone: 650 525 5535

Last updated: 2024-11-08